These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16372334)

  • 41. Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.
    Hooker S; Hernandez W; Chen H; Robbins C; Torres JB; Ahaghotu C; Carpten J; Kittles RA
    Prostate; 2010 Feb; 70(3):270-5. PubMed ID: 19902474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study.
    Lavender NA; Benford ML; VanCleave TT; Brock GN; Kittles RA; Moore JH; Hein DW; Kidd LC
    BMC Cancer; 2009 Nov; 9():397. PubMed ID: 19917083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
    Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
    Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.
    Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
    Int J Cancer; 2002 Aug; 100(6):683-5. PubMed ID: 12209606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
    Oakley-Girvan I; Feldman D; Eccleshall TR; Gallagher RP; Wu AH; Kolonel LN; Halpern J; Balise RR; West DW; Paffenbarger RS; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1325-30. PubMed ID: 15298953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
    Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
    Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.
    Lubahn J; Berndt SI; Jin CH; Klim A; Luly J; Wu WS; Isaacs S; Wiley K; Isaacs WB; Suarez BK; Hayes RB; Kibel AS
    Prostate; 2010 May; 70(6):646-53. PubMed ID: 20033885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans.
    Bonilla C; Hooker S; Mason T; Bock CH; Kittles RA
    PLoS One; 2011 Feb; 6(2):e16044. PubMed ID: 21358824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer.
    Kidd LR; Coulibaly A; Templeton TM; Chen W; Long LO; Mason T; Bonilla C; Akereyeni F; Freeman V; Isaacs W; Ahaghotu C; Kittles RA
    Prostate Cancer Prostatic Dis; 2006; 9(3):284-92. PubMed ID: 16733517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
    Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
    Wang Y; Ray AM; Johnson EK; Zuhlke KA; Cooney KA; Lange EM
    Prostate; 2011 Feb; 71(3):225-31. PubMed ID: 20717903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
    Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
    Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ancestry, genetic susceptibility, E-cadherin-160A and prostate cancer risk-is there an association?
    Macoska JA
    J Urol; 2006 Aug; 176(2):435-6. PubMed ID: 16813859
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.